Skip to main content
PSEC
NASDAQ Unknown

Prospect Capital Seeks Shareholder Approval to Renew Below-NAV Stock Sales Authorization

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Asset Management Stocks · Financial
Sentiment info
Negative
Importance info
7
Price
$2.74
Mkt Cap
$1.322B
52W Low
$2.45
52W High
$4.45
52W Position info
12% above low
Off High info
38% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

PSEC is trading near its 52-week low of $2.45 (12% above the low).

Summary

Prospect Capital is asking shareholders to renew authorization to sell common stock below Net Asset Value for 12 months, a move crucial for capital access but potentially dilutive.


Key Events · Financing and Capital Events · PSEC

  • Shareholder Vote on Below-NAV Stock Sales

    The company is seeking to renew authorization to sell common stock below its Net Asset Value (NAV) for the next 12 months. This is a recurring request for BDCs to maintain capital flexibility.

  • Significant Dilution Potential

    The authorization allows for sales of up to 25% of outstanding common stock on any given date, with no limit on the number of offerings. The filing includes hypothetical examples demonstrating substantial dilution for non-participating shareholders.

  • Strategic Capital Access

    This flexibility is deemed essential for the company to access capital in volatile markets, fund new investments, repay debt, and maintain its regulatory asset coverage ratio, especially as its stock consistently trades at a deep discount to NAV.

  • Follows Recent Capital Raising Efforts

    This proxy statement follows the company's recent universal shelf registration (N-2ASR on 2026-02-10) and an increase in its preferred stock offering (8-K on 2026-02-11), indicating a concerted effort to enhance its capital structure.


Analysis · PSEC · Unknown

Prospect Capital Corporation is seeking shareholder approval to renew its authorization to sell common stock at a price below its Net Asset Value (NAV) for the next 12 months. This is a critical vote for shareholders as it grants the company significant flexibility to raise capital, but also carries the risk of substantial dilution. The company, a Business Development Company (BDC), frequently trades below NAV, making this authorization a necessary tool for maintaining capital access, funding new investments, and adhering to regulatory asset coverage ratios. The filing explicitly details the potential dilutive effects on existing shareholders, who could see a reduction in NAV per share and a decrease in their percentage ownership if they do not participate in future offerings. This renewal follows a recent universal shelf registration (N-2ASR on 2026-02-10) and an increase in preferred stock offering size (8-K on 2026-02-11), indicating an ongoing strategy to bolster capital.

At the time of this filing, PSEC was trading at $2.74 on NASDAQ in the Unknown sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $2.45 to $4.45. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PSEC - Latest Insights

PSEC
Jul 07, 2026, 5:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.20
Real-time Price: $2.21 info
Change: +$0.0098 (+0.45%) info
Market Cap: $1.107B info
PSEC
Jun 25, 2026, 4:59 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $2.28
Real-time Price: $2.21 info
Change: -$0.070 (-3%) info
Market Cap: $1.107B info
PSEC
Jun 24, 2026, 3:58 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $2.21
Real-time Price: $2.21 info
Change: $0 (0%) info
Market Cap: $1.107B info
PSEC
May 27, 2026, 4:06 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $2.37
Real-time Price: $2.21 info
Change: -$0.160 (-7%) info
Market Cap: $1.107B info
PSEC
May 27, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $2.36
Real-time Price: $2.21 info
Change: -$0.150 (-6%) info
Market Cap: $1.107B info